Clinical Trial Update: Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa [Phase 4]

View source ↗

Summary

Phase 4 trial comparing boosted atazanavir with Truvada vs boosted darunavir with maraviroc and Kivexa in treatment-naive HIV-1 subjects assessing cerebral func…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Impaired Cognition Related to HIV

Drugs mentioned

• ATV/r + Truvada (atazanavir boosted with ritonavir + emtricitabine/tenofovir disoproxil fumarate)
• DRV/r + maraviroc + Kivexa (darunavir boosted with ritonavir + maraviroc + abacavir/lamivudine)

Snippet

Sponsor: Imperial College London | Conditions: HIV, Impaired Cognition | Phase 4 | Status: COMPLETED | Results posted: 2019-10-21